Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPM6B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRPF3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPP3CC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PIP4K2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DEK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMPO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HNRNPD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KPNA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100506248 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
IRF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
ZNF160 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LBR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WNK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
THUMPD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ERLIN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RIC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANKRD36B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on